Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Tim Ford. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tim Ford or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

#77 - Mike Phillips on Ironman NZ & Imogen Simmonds Tests Positive!

1:01:35
 
Share
 

Manage episode 470079823 series 35794
Content provided by Tim Ford. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tim Ford or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

This week, we discuss the recent news that Imogen Simmonds tested positive for Ligandrol, a selective androgen receptor modulator (SARM) known to enhance muscle mass and strength. Simmonds has denied intentional use, attributing the positive test to intimate contact with her partner, who was unknowingly taking Ligandrol to improve his physique. We explore the details of this case, its implications for her career, and the broader impact on the sport.

We then sit down with Mike Phillips, the new Ironman New Zealand champion and course record holder, to hear how his race unfolded and what this result means for the rest of his season.

Finally, we recap all the action from Ironman New Zealand, breaking down the key performances, race dynamics, and standout moments from Taupō.

To support the podcast please head to: patreon.com/talkingtriathlon

To watch this podcast as a video visit: https://bit.ly/3vzSss2

Or check us out on Social Media:

Instagram: https://www.instagram.com/talkingtriathlon

You can follow James at https://www.instagram.com/bale.james85

You can follow Tim at https://www.instagram.com/tford14

You can follow Mike at https://www.instagram.com/mikephillipsnz

  continue reading

343 episodes

Artwork
iconShare
 
Manage episode 470079823 series 35794
Content provided by Tim Ford. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tim Ford or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

This week, we discuss the recent news that Imogen Simmonds tested positive for Ligandrol, a selective androgen receptor modulator (SARM) known to enhance muscle mass and strength. Simmonds has denied intentional use, attributing the positive test to intimate contact with her partner, who was unknowingly taking Ligandrol to improve his physique. We explore the details of this case, its implications for her career, and the broader impact on the sport.

We then sit down with Mike Phillips, the new Ironman New Zealand champion and course record holder, to hear how his race unfolded and what this result means for the rest of his season.

Finally, we recap all the action from Ironman New Zealand, breaking down the key performances, race dynamics, and standout moments from Taupō.

To support the podcast please head to: patreon.com/talkingtriathlon

To watch this podcast as a video visit: https://bit.ly/3vzSss2

Or check us out on Social Media:

Instagram: https://www.instagram.com/talkingtriathlon

You can follow James at https://www.instagram.com/bale.james85

You can follow Tim at https://www.instagram.com/tford14

You can follow Mike at https://www.instagram.com/mikephillipsnz

  continue reading

343 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play